GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2025

Type / Class: Equity / Common Stock, par value $0.001 per share
Symbol: GLYC on Nasdaq
Price per share: $0.25

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
Weinstein Benjamin	0.1%		$10,000		50,000		Weinstein Benjamin	30 Oct 2024

Institutional Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2025 Q2	0	$0	-$6,455,751	$0	$0	$0.25	0
2025 Q1	30,740,623	$6,455,829	+$54,630	$4,368	$16,989	$0.21	32
2024 Q4	30,349,512	$7,556,907	+$3,360,064	$349	$12,699	$0.25	38
2024 Q3	17,787,810	$3,003,325	-$2,735,568	$0	$0	$0.17	34
2024 Q2	25,554,956	$7,195,771	-$32,011,619	$43,169	$545,643	$0.28	37
2024 Q1	36,846,967	$110,538,682	+$5,323,549	$1,909,200	$2,907,600	$3.00	71
2023 Q4	35,101,664	$82,836,847	+$1,025,276	$65,844	$170,156	$2.36	57
2023 Q3	34,706,628	$52,060,131	-$1,381,293	$31,050	$347,250	$1.50	47
2023 Q2	35,591,469	$61,923,460	-$2,358,185	$92,394	$211,758	$1.74	53
2023 Q1	36,991,329	$46,608,472	+$10,727,679	$588,293	$566,418	$1.26	52
2022 Q4	27,502,473	$83,329,939	+$4,920,703	$1,818	$492,984	$3.03	47
2022 Q3	25,944,512	$14,312,754	-$391,818		$0	$0.55	30
2022 Q2	26,459,719	$15,820,424	-$794,298		$37,000	$0.60	32
2022 Q1	27,407,909	$31,241,208	-$2,635,967	$0	$127,000	$1.14	39
2021 Q4	29,684,722	$42,741,693	-$358,257	$415,000	$255,000	$1.44	43
2021 Q3	29,651,608	$64,934,187	-$3,250,011	$576,000	$685,000	$2.19	46
2021 Q2	31,212,925	$72,414,257	-$13,459,111	$813,000	$947,000	$2.32	56
2021 Q1	36,466,363	$109,763,364	-$8,132,030	$745,000	$584,000	$3.01	75
2020 Q4	38,695,728	$145,485,542	+$647,785	$611,000	$133,006	$3.76	88
2020 Q3	40,424,040	$124,106,270	-$2,168,977	$204,000	$2,819,000	$3.07	77
2020 Q2	38,071,637	$143,145,870	+$3,277,243	$243,000	$41,000	$3.76	83
2020 Q1	36,884,841	$84,096,867	-$5,054,796			$2.28	72
2019 Q4	41,198,307	$217,940,933	-$1,820,058		$1,000	$5.29	75
2019 Q3	41,581,117	$179,215,502	-$88,453,588	$0	$56,000	$4.31	70
2019 Q2	44,872,521	$534,859,693	+$51,529,720	$1,453,000	$2,000	$11.92	76
2019 Q1	45,441,767	$566,235,993	+$4,645,723	$194,000	$373,000	$12.46	75
2018 Q4	45,207,365	$428,101,787	-$17,690,144	$0	$0	$9.47	81
2018 Q3	46,304,532	$666,790,541	-$2,168,664	$683,000	$1,002,000	$14.40	83
2018 Q2	46,332,380	$747,337,222	+$44,887,255	$994,000	$1,523,000	$16.13	84
2018 Q1	43,532,023	$706,521,000	+$188,050,968	$1,167,000	$5,372,000	$16.23	81
2017 Q4	31,891,452	$535,458,000	+$35,683,836	$2,198,000	$640,000	$16.79	80
2017 Q3	29,749,439	$416,193,007	-$2,747,490	$192,000	$0	$13.99	54
2017 Q2	30,307,649	$338,226,804	+$128,049,645	$1,115,000	$336,000	$11.16	68
2017 Q1	19,122,501	$103,840,000	+$4,641,930			$5.43	41
2016 Q4	18,926,207	$115,448,000	+$2,928,927			$6.10	47
2016 Q3	18,403,420	$131,581,591	-$753,008			$7.15	45
2016 Q2	18,503,424	$134,518,808	+$32,318,988			$7.27	48
2016 Q1	14,058,844	$83,772,000	+$1,182,823			$5.96	27
2015 Q4	13,866,671	$79,306,000	+$278,790			$5.72	26
2015 Q3	13,820,530	$77,389,000	+$291,921			$5.60	29
2015 Q2	13,756,698	$109,349,000	+$159,929			$7.95	28
2015 Q1	13,744,936	$114,357,000	-$1,010,696			$8.32	27
2014 Q4	13,897,321	$100,057,000	+$1,909,766			$7.20	25
2014 Q3	13,397,783	$92,978,298	-$1,099,196			$6.94	24
2014 Q2	13,516,993	$113,943,965	-$7,929,067			$8.43	30
2014 Q1	14,070,204	$229,767,000	+$229,767,070			$16.33	36